Wednesday, November 01, 2017 1:44:58 PM
https://www.otcmarkets.com/stock/IGEX/news
ATLANTA, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Indo Global Exchanges Pte Ltd (OTC:IGEX) A U.S. based creditor of Indo Global Exchanges Pte Ltd would like to disclose to investors four notes held in Indo Global Exchanges Pte Ltd not listed in Indo Global Exchanges Pte Ltd financial statements for the fiscal years ended July 31, 2014, July 31, 2015 and July 31, 2016.
The U.S. based creditor invested funds directly into Indo Global Exchanges Pte Ltd on three separate occasions and purchased a note from a third-party note holder.
Note 1: $15,000 12% Convertible Promissory Note dated October 8, 2015. Convertible at the lower of (1) 50% multiplied by the Market Price (representing a discount rate of 50%), or (2) .0004 per share. This note has a 9.99% conversion blocker.
Note 2: $10,000 12% Convertible Promissory Note dated November 2, 2015. Convertible at the lower of (1) 50% multiplied by the Market Price (representing a discount rate of 50%), or (2) .0001 per share. This note has a 9.99% conversion blocker.
Note 3: $10,000 12% Convertible Promissory Note dated November 2, 2015. Convertible at the lower of (1) 50% multiplied by the Market Price (representing a discount rate of 50%), or (2) .0001 per share. This note has a 9.99% conversion blocker.
Note 4: On October 29, 2015 the U.S. based investor purchased an $18,049 promissory note dated June 6, 2014 in full ($18,049) from a third party and exchanged the original note for a 8% Convertible Promissory Note dated October 29, 2015. The note is Convertible at the lower of (1) 50% multiplied by the Market Price (representing a discount rate of 50%), or (2) .0001 per share. This note has a 9.99% conversion blocker.
FOR THE U.S. BASED INVESTOR:
David Kugelman
Atlanta Capital Partners, LLC
(404) 856-9157
(866) 692-6847 Toll Free - U.S. And Canada
dk@atlcp.com
Recent IGEX News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 09:09:59 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM